Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Express Scripts
Moodys
Baxter
Merck

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

ZIPSOR Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Zipsor, and when can generic versions of Zipsor launch?

Zipsor is a drug marketed by Assertio and is included in one NDA. There are eight patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-seven patent family members in nineteen countries.

The generic ingredient in ZIPSOR is diclofenac potassium. There are forty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.

Drug patent expirations by year for ZIPSOR
Drug Prices for ZIPSOR

See drug prices for ZIPSOR

Drug Sales Revenue Trends for ZIPSOR

See drug sales revenues for ZIPSOR

Recent Clinical Trials for ZIPSOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
DepomedPhase 4
Hospira, Inc.Phase 1
Mayo ClinicPhase 2/Phase 3

See all ZIPSOR clinical trials

Recent Litigation for ZIPSOR

Identify potential future generic entrants

District Court Litigation
Case NameDate
PATHEON SOFTGELS INC. v. PURACAP PHARMACEUTICAL LLC2018-10-05
DEPOMED, INC. v. BANNER PHARMACAPS INC.2013-07-26

See all ZIPSOR litigation

Pharmacology for ZIPSOR
Synonyms for ZIPSOR
15307-81-0
15307-86-5 (Parent)
2-((2,6-dichlorophenyl)amino)benzeneacetic acid, monopotassium salt
AB0013318
AC-18735
AKOS015889752
AKOS015994733
AN-8291
Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monopotassium salt
C14H10Cl2KNO2
C14H10Cl2NO2.K
Cambia
Cambia (TN)
Cataflam
Cataflam (TN)
CGP 45840B
CGP-45840B
CHEBI:4508
CHEMBL1200804
D00903
Diclofenac potassium
Diclofenac potassium (USAN)
Diclofenac potassium [USAN:USP]
Diclofenac potassium [USAN]
DTXSID30165212
FT-0603076
H866
HMS3656D18
I01-3215
KS-5037
KXZOIWWTXOCYKR-UHFFFAOYSA-M
L4D5UA6CB4
LS-173441
MolPort-005-937-655
Potassium (o-(2,6-dichloroanilino)phenyl)acetate
potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
potassium 2-[2-(2,6-dichloroanilino)phenyl]acetate
potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
PubChem5895
s3062
SC-01315
SCHEMBL40784
SW196404-4
UNII-L4D5UA6CB4
Voltfast
Zipsor (TN)

US Patents and Regulatory Information for ZIPSOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Assertio ZIPSOR diclofenac potassium CAPSULE;ORAL 022202-001 Jun 16, 2009 AB RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Assertio ZIPSOR diclofenac potassium CAPSULE;ORAL 022202-001 Jun 16, 2009 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Assertio ZIPSOR diclofenac potassium CAPSULE;ORAL 022202-001 Jun 16, 2009 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Assertio ZIPSOR diclofenac potassium CAPSULE;ORAL 022202-001 Jun 16, 2009 AB RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Assertio ZIPSOR diclofenac potassium CAPSULE;ORAL 022202-001 Jun 16, 2009 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZIPSOR
Drugname Dosage Strength RLD Date
➤ Subscribe Capsules 25 mg ➤ Subscribe   Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Mallinckrodt
Dow
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.